Skip to content
GenoLensGenoLens

NR4A2

Chr 2q24.1

nuclear receptor subfamily 4 group A member 2

Aliases:
TINUR, NOT, RNR1, HZF-3
MANE:
ENST00000339562.9

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Adult onset neurodegenerative disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset dystonia, chorea or related movement disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Parkinson Disease and Complex Parkinsonism

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism

    0.75
  • neurodevelopmental disorder

    0.46
  • Parkinson disease

    0.45
  • complex neurodevelopmental disorder

    0.44
  • late-onset Parkinson disease

    0.42
  • Hereditary late-onset Parkinson disease

    0.42
  • hereditary disease

    0.41
  • autosomal dominant dopa-responsive dystonia

    0.37
  • prostatitis

    0.31
  • drug allergy

    0.31

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Nuclear receptor subfamily 4 group A member 2

Transcriptional regulator which is important for the differentiation and maintenance of meso-diencephalic dopaminergic (mdDA) neurons during development (PubMed:15716272, PubMed:17184956). It is crucial for expression of a set of genes such as SLC6A3, SLC18A2, TH and DRD2 which are essential for development of mdDA neurons (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.